Risedronate Delayed-Release

The U.S. Food and Drug Administration has approved the drug risedronate delayed-release to treat osteoporosis in postmenopausal women. The medication comes in tablet form and is only taken once a week, ideally before breakfast. In addition, you need to stay in an upright position for at least 30 minutes after taking it. Commonly reported side effects include joint pain, diarrhea, and stomach pain.

What Is Risedronate Delayed-Release?

Risedronate delayed-release (Atelvia™) is a prescription medication approved for treating osteoporosis in postmenopausal women. It comes in a unique delayed-release tablet that eliminates the need to wait to eat or drink until 30 minutes after taking the tablet, unlike other medications in its class. In fact, risedronate delayed-release is designed to be taken right after breakfast.
 
(Click What Is Risedronate Delayed-Release Used For? for more information on this topic, including possible off-label uses.)
 

Are There Side Effects?

As with any medicine, side effects are possible with risedronate delayed-release. However, not everyone who takes the drug will experience problems. In fact, most people tolerate it quite well.
 
If side effects do occur, in most cases, they are minor and either require no treatment or are treated easily by you or your healthcare provider. Serious reactions are less common.
 
Common side effects seen with risedronate delayed-release include but are not limited to:
 
(Click Side Effects of Risedronate Delayed-Release to learn more, including potentially serious side effects you should report immediately to your healthcare provider.)
 
Risedronate Delayed-Release Article Continues on Next Page >
Written by/reviewed by: Kristi Monson, PharmD; Arthur Schoenstadt, MD
Last reviewed by: Kristi Monson, PharmD
 
Other Articles in This eMedTV Presentation
Referring Pages Articles Health Topics Drugs & Supplements